Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)Completed
NCT04410991Phase 3Updated Jul 2, 2025
Sponsor: Sanofi
Relapsing Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Canada +23 more
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) StudyCompleted
NCT05518487Phase 2Updated Jun 25, 2025
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19 · Kidney Transplant
United States
Ultra Curto (Ultra Short) TB Prevention TherapyCompleted
NCT04703075Phase 4Updated Jun 19, 2025
Sponsor: Johns Hopkins University
Tuberculosis
Brazil
Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive TestingTerminated
NCT05699265N/AUpdated Jun 19, 2025
Sponsor: Children's Hospital Medical Center, Cincinnati
Fabry Disease
United States
Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive Not Recruiting
NCT04942210Phase 2Updated Jun 18, 2025
Sponsor: Sanofi Pasteur, a Sanofi Company
Yellow Fever · Healthy Volunteers
United States
Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular DegenerationActive Not Recruiting
NCT01736592Phase 2Updated Jun 12, 2025
Sponsor: Sanofi
Stargardt's Disease
United States, France
Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)Terminated
NCT04394624Phase 2Updated Jun 6, 2025
Sponsor: Sanofi
Non-small Cell Lung Cancer Metastatic
United States, Bulgaria, Czechia, Portugal, South Korea +1 more
Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced MalignanciesTerminated
NCT04418661Phase 1, Phase 2Updated May 29, 2025
Sponsor: Sanofi
Metastatic Neoplasm
United States, Argentina, Australia, Chile, South Korea +2 more
Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)Completed
NCT05780151Phase 4Updated May 29, 2025
Sponsor: Mira Zuidgeest
Diabetes Mellitus, Type 2
Denmark, Germany, United Kingdom
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationCompleted
NCT04456673Phase 3Updated May 29, 2025
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Belgium, Brazil +24 more
Cabazitaxel With Radiation and Hormone Therapy for Prostate CancerCompleted
NCT01420250Phase 1Updated May 15, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Prostate Cancer
United States
ATG Plus PTCy vs ATG for CGVHD ProphylaxisActive Not Recruiting
NCT04202835Phase 2Updated May 11, 2025
Sponsor: McMaster University
Acute Leukemia · Myelodysplasia · Chronic Graft-versus-host-disease
Australia, Canada
Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)Terminated
NCT05545072Phase 3Updated May 8, 2025
Sponsor: Emory University
Allergic Fungal Rhinosinusitis
United States
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based ChemotherapyCompleted
NCT01437488Phase 2Updated May 4, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Urothelial Carcinoma
United States
Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213Completed
NCT05305989Phase 2Updated May 2, 2025
Sponsor: Kadmon, a Sanofi Company
Chronic Graft-versus-host-disease
United States
Docetaxel Versus Cabazitaxel Post Abiraterone or EnzalutamideTerminated
NCT03764540Phase 2Updated Apr 13, 2025
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Metastatic Prostate Cancer
Canada
Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMMActive Not Recruiting
NCT04891809Phase 2Updated Apr 10, 2025
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Newly Diagnosed Multiple Myeloma
Austria, Greece, Serbia
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor TherapyCompleted
NCT03132636Phase 2Updated Apr 8, 2025
Sponsor: Regeneron Pharmaceuticals
Carcinoma, Basal Cell
United States, Austria, Belgium, Canada, France +5 more
Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 YearsCompleted
NCT03694392N/AUpdated Apr 8, 2025
Sponsor: Kaiser Permanente
Influenza · Pneumonia · Lower Respiratory Tract Infection · Acute Myocardial Infarction
United States
the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY DiseaseRecruiting
NCT06776419N/AUpdated Apr 8, 2025
Sponsor: Caroline Michaela Kistorp
Fabry Disease · Cardiovascular Diseases
Denmark
Study of Cemiplimab in Adults With Cervical CancerCompleted
NCT03257267Phase 3Updated Apr 8, 2025
Sponsor: Regeneron Pharmaceuticals
Squamous Cell Carcinoma (SCC) · Recurrent or Metastatic, Platinum-refractory Cervical Cancer
United States, Australia, Belgium, Brazil, Canada +9 more
Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY DiseaseRecruiting
NCT06325488N/AUpdated Apr 6, 2025
Sponsor: Caroline Michaela Kistorp
Fabry Disease · Chronic Kidney Diseases
Denmark
Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid TumorsTerminated
NCT05429762Phase 1Updated Apr 6, 2025
Sponsor: Sanofi
Neoplasm
United States, Belgium, France, Spain, Turkey (Türkiye)
Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)Completed
NCT04442269Phase 2Updated Apr 4, 2025
Sponsor: Regeneron Pharmaceuticals
Allergic Bronchopulmonary Aspergillosis
United States, Bulgaria, France, Germany, Hungary +5 more
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple SclerosisRecruiting
NCT06068582NAUpdated Apr 3, 2025
Sponsor: Amsterdam UMC, location VUmc
Multiple Sclerosis
Netherlands

Previous page Next page